Literature DB >> 28185659

Change in Maximal Exercise Capacity Is Associated With Survival in Men and Women.

Clinton A Brawner1, Mouaz H Al-Mallah2, Jonathan K Ehrman3, Waqas T Qureshi4, Michael J Blaha5, Steven J Keteyian3.   

Abstract

OBJECTIVE: To describe the relationship between change in maximal exercise capacity (MEC) over time and risk of all-cause mortality separately in men and women. PATIENTS AND METHODS: Consecutive patients (n=10,854; mean ± SD age, 54±11 years; 43% women; 30% nonwhite) who completed 2 physician-referred exercise tests between January 2, 1991, and May 28, 2009, were identified from the Henry Ford Exercise Testing (FIT) Project. The MEC was quantified in metabolic equivalents of task (METs) calculated from peak workload on a treadmill and adjusted to the equivalent for a 50-year-old man. Multivariable Cox proportional hazards regression was performed to assess risk of all-cause mortality associated with change in MEC based on (1) change from age-/sex-adjusted low fitness (<8 METs) to intermediate or high fitness and (2) an absolute change in METs.
RESULTS: Relative to patients with low fitness at both tests, increasing from low to intermediate or high fitness was associated with lower risk of all-cause mortality (adjusted hazard ratio [aHR] = 0.63 [95% CI, 0.45-0.87] in men and 0.56 [95% CI, 0.34-0.91] in women). Each 1-MET increase in age-/sex-adjusted MEC between baseline and follow-up was associated with an aHR of 0.87 (95% CI, 0.84-0.91) in men and 0.84 (95% CI, 0.79-0.89) in women, with no significant interaction by sex (P=.995). Similar aHRs were observed in a subgroup with intermediate fitness at baseline.
CONCLUSION: In men and women referred for an exercise stress test, change in MEC over time is inversely related to risk of all-cause mortality.
Copyright © 2017 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28185659     DOI: 10.1016/j.mayocp.2016.12.016

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  7 in total

1.  [Protective effect of cardiopulmonary fitness on patients with high risk of atherosclerotic cardiovascular disease].

Authors:  C Ren; X Y Wu; W Zhao; L Y Tao; P Liu; W Gao
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2020-02-18

Review 2.  Cardiorespiratory Fitness and Cardiovascular Disease Prevention: an Update.

Authors:  Mouaz H Al-Mallah; Sherif Sakr; Ada Al-Qunaibet
Journal:  Curr Atheroscler Rep       Date:  2018-01-16       Impact factor: 5.113

3.  Inverse Relationship of Maximal Exercise Capacity to Hospitalization Secondary to Coronavirus Disease 2019.

Authors:  Clinton A Brawner; Jonathan K Ehrman; Shane Bole; Dennis J Kerrigan; Sachin S Parikh; Barry K Lewis; Ryan M Gindi; Courtland Keteyian; Khaled Abdul-Nour; Steven J Keteyian
Journal:  Mayo Clin Proc       Date:  2020-10-10       Impact factor: 7.616

4.  Fitness, Fatness, and Mortality in Men and Women From the UK Biobank: Prospective Cohort Study.

Authors:  Jakob Tarp; Anders Grøntved; Miguel A Sanchez-Lastra; Knut Eirik Dalene; Ding Ding; Ulf Ekelund
Journal:  J Am Heart Assoc       Date:  2021-03-13       Impact factor: 5.501

5.  Differences in Exercise Capacity and Responses to Training in 24 Inbred Mouse Strains.

Authors:  Joshua J Avila; Seung Kyum Kim; Michael P Massett
Journal:  Front Physiol       Date:  2017-11-30       Impact factor: 4.566

Review 6.  Systematic Review and Meta-Analysis of Endurance Exercise Training Protocols for Mice.

Authors:  Michael P Massett; Caitlyn Matejka; Hyoseon Kim
Journal:  Front Physiol       Date:  2021-12-02       Impact factor: 4.566

7.  A patient-centered multidisciplinary cardiac rehabilitation program improves glycemic control and functional outcome in coronary artery disease after percutaneous and surgical revascularization.

Authors:  Andrea Denegri; Valentina A Rossi; Fabrizio Vaghi; Paolo Di Muro; Martino Regazzi; Tiziano Moccetti; Elena Pasotti; Giovanni B Pedrazzini; Mauro Capoferri; Marco Moccetti
Journal:  Cardiol J       Date:  2020-02-10       Impact factor: 2.737

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.